The glutamatergic dysfunction hypothesis for schizophrenia

Harvard Review of Psychiatry

Volumn 3, Issue 5, 1996, Pages 241-253

  Coyle, Joseph T ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; PHENCYCLIDINE;

BRAIN CORTEX; HUMAN; HYPOTHESIS; LIMBIC SYSTEM; NEGATIVE SYNDROME; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0030044715     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229609017192     Document Type: Review

References (9)

1. Goldstein J. Sampling biases in studies of gender and schizophrenia. Schizophr Bull 1993;19:9-14.
2. Kraepelin E. Dementia praecox and paraphrenia. Edinburgh: Livingston, 1919.
3. Kendler KS, Diehl SR. The genetics of schizophrenia: a current genetic-epidemiologic perspective. Schizophr Bull 1993;19:261-85.
4. Stabenah JR, Pollin W. Heredity and environment in schizo-phrenia revisited: the contribution of twin and high-risk studies. J Nerv Ment Dis 1993;181:290-7.
5. Crow TJ. Molecular pathology of schizophrenia: more than one disease process. BMJ 1980;280:66-8.
6. Arndt S, Andreasen N, Flavum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Arch Gen Psychiatry 1995;52:352-60.
7. Bland RC, Orn H. Fourteen-year outcome in early schizophrenia. Acta Psychiatr Scand 1979;58:327-38.
8. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239-46.
9. Heaton RK, Drexler M. Clinical neuropsychological findings in schizophrenia and aging. In: Miller NE, Cohen GD, eds. Schizophrenia and aging: schizophrenia, paranoia, and schizophreniform disorders in later life. New York: Guilford, 1987:145-61.